Emerging roles of tRNA in cancer

Daixi Ren1, Yongzhen Mo1, Mei Yang1

  • 1NHC Key Laboratory of Carcinogenesis and Hunan Key Laboratory of Cancer Metabolism, Hunan Cancer Hospital and the Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, China; Key Laboratory of Carcinogenesis and Cancer Invasion of the Chinese Ministry of Education, Cancer Research Institute, Central South University, Changsha, China.

Cancer Letters
|April 13, 2023
PubMed

Insights

Transfer RNAs (tRNAs) are crucial for genetic information. Abnormalities and modifications in tRNAs and their fragments (tRFs) are linked to cancer development and progression.

Area of Science:

  • Molecular Biology
  • Genetics
  • Biochemistry

Background:

  • Transfer RNAs (tRNAs) are essential molecules for protein synthesis and genetic information transfer.
  • Aberrant tRNA modifications disrupt translation and are implicated in various diseases, including cancer.
  • tRNA instability can lead to the formation of small tRNA fragments (tRFs), which have regulatory roles in tumorigenesis.

Purpose of the Study:

  • To investigate the role of tRNA modifications and tRF formation in cancer.
  • To elucidate the mechanisms underlying abnormal tRNA metabolism in pathological conditions.
  • To explore the potential of targeting tRNA pathways for cancer prevention and treatment.

Main Methods:

  • Analysis of tRNA modifications and their impact on tRNA stability.
  • Investigation of RNase activity involved in tRNA cleavage into tRFs.
  • Study of the regulatory functions of tRFs in cancer cell models.

Main Results:

  • Dysregulation of tRNA modifications is a significant factor in carcinogenesis.
  • Impaired tRNA stability leads to the generation of tRFs.
  • The precise mechanisms of tRF formation in cancer require further elucidation.

Conclusions:

  • Understanding aberrant tRNA modifications and tRF formation is crucial for comprehending tRNA metabolism in cancer.
  • These insights may pave the way for novel cancer prevention and therapeutic strategies.

Related Concept Videos

Transfer RNA Synthesis02:36

Transfer RNA Synthesis

One of the unique features of tRNA is the presence of modified bases. In some tRNAs, modified bases account for nearly 20% of the total bases in the molecule. Altogether, these unusual bases protect the tRNA from enzymatic degradation by RNases.
Each of these chemical modifications is carried by a specific enzyme, post-transcription. All of these enzymes have unique base and site-specificity. Methylation, the most common chemical modification, is carried by at least nine different enzymes, with...
12.1K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.6K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.7K
Translation01:31

Translation

Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Proteins are...
15.0K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.7K